Coexistence of Hemoglobin D and Thalassemia Trait: A Rare Phenomenon with Cardiac Presentation

Archana Nimesh1, Rajani Kumawat1, Akhilesh Pathak2

  • 1Department of Biochemistry, All India Institute of Medical Sciences, Bathinda, Punjab, India.

PubMed

Insights

Hemoglobin D (HbD) with thalassemia trait can cause severe cardiac issues, even if typically asymptomatic. This case highlights the need for better hemoglobinopathy evaluation, especially where genetic testing is limited.

Area of Science:

  • Hematology
  • Genetics
  • Clinical Medicine

Background:

  • Hemoglobin D (HbD) is a common hemoglobin variant in South Asia, arising from a specific amino acid substitution.
  • HbD is usually asymptomatic but can cause clinical issues when co-inherited with other hemoglobinopathies like sickle cell disease or thalassemia.
  • Co-inheritance of HbD and thalassemia is rare and poorly documented, with limited understanding of its clinical presentation.

Purpose of the Study:

  • To report a rare case of coexisting Hemoglobin D and thalassemia trait presenting with severe cardiac symptoms.
  • To propose a diagnostic algorithm for efficient hemoglobinopathy evaluation in resource-limited settings.
  • To raise awareness about potential severe clinical manifestations of combined hemoglobin variants.

Main Methods:

  • Case report detailing a patient from Punjab with coexisting HbD and thalassemia trait.
  • Clinical assessment focusing on severe cardiac symptoms potentially linked to chronic anemia.
  • Development of a diagnostic algorithm for hemoglobinopathy evaluation.

Main Results:

  • A patient with coexisting HbD and thalassemia trait presented with severe cardiac symptoms, suggesting a link to chronic anemia.
  • The case underscores the potential for significant clinical impact from rare hemoglobin variant combinations.
  • An algorithm was proposed to aid in the diagnosis of hemoglobinopathies.

Conclusions:

  • Co-inheritance of Hemoglobin D and thalassemia trait can lead to severe clinical manifestations, including cardiac complications.
  • The proposed diagnostic algorithm can aid clinicians in evaluating hemoglobinopathies, especially where genetic testing is not readily available.
  • Early and accurate diagnosis of hemoglobinopathies is crucial for managing potential complications and improving patient outcomes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
38.0K
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
7.5K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
514
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
500